Corrigendum to “A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer” [Biomed. Pharmacother. 184 (2025) 117899] - 14/03/25

Xia Xue ^a, 1

  Xia Xue and Yongjia Zhou contributed equally to this work.

, Yongjia Zhou ^b, 1

  Xia Xue and Yongjia Zhou contributed equally to this work.

, Huiping Liu ^c, Yan Gao ^a, Xinyu Ma ^a, Zhaohua Xiao ^b, Wenhao Zhang ^b, Peichao Li ^{b, d}, Zhongxian Tian ^{b, d}, Yun Luan ^e, Xiaogang Zhao ^{b, d, ⁎}

^a Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China 

^b Department of Thoracic Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China 

^c School of Pharmacy, Yantai University, Yantai 264005, China 

^d Key Laboratory of Thoracic Cancer in Universities of Shandong, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China 

^e Central Laboratory, Institute of Medical Science, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China 

^⁎Corresponding author at: Department of Thoracic Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, 250033, China.Department of Thoracic Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University250033China

Le texte complet de cet article est disponible en PDF.